Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Tammie, Kelsey"'
Autor:
Sam Frank, Michele Goldstein, Tammie Kelsey, Merit Cudkowicz, Kimberly L. Ferrante, Elisabeth A. de Blieck, Joseph Weber, Linda Metakis, Bernard Ravina, Ira Shoulson, Robert J. Ferrante, Karl Kieburtz, Danna Jennings, Francis O. Walker, Arthur Watts, Peter Como, Michael P. McDermott, Vicki Hunt, H. Christopher Hyson, Carol Zimmerman, Susan E. Browne, Susan Daigneault, M. Flint Beal, Kristyn Newhall
Publikováno v:
Movement Disorders. 25:1924-1928
Coenzyme Q10 (CoQ(10)), a potential neuroprotective compound, was previously investigated at a dosage of 600 mg/day in Huntington's disease (HD) patients and demonstrated a trend toward slowing disease progression. Higher CoQ(10) dosages may prove be
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::57941278e1c9c8de99960544f058b2a4
https://doi.org/10.1002/mds.22408
https://doi.org/10.1002/mds.22408
Autor:
Margaret Marie Cox, Stephanie Sendek, Margaret F. Turk, Julie H. Carter, Susan C. Fagan, Lorelei Derwent, Oksana Suchowersky, Jay S. Schneider, Linda Paul, Gwyn Vernon, Stephen Gollomp, Karl Kieburtz, Debbie Baker, I. Van Bodis-Wollner, Germaine McInnes, Marian A. Perez, G. Webster Ross, Katharine Pabst, Jorge L. Juncos, Chad W. Christine, Jessie Roth, Joseph M. Savitt, Peter A LeWitt, Hubert H. Fernandez, Matthew Brodsky, Mark F. Lew, Jay M. Gorell, Natividad R. Stover, Paulo Guimaraes, Andrew Feigin, Anita Blenke, Martha Nance, Elizabeth Hayes, Andrew Siderowf, W.R. Wayne Martin, Tammie Kelsey, Susan Bennett, Sharon McCarthy, Charles H. Adler, Beverly Olsen, Pauline LeBlanc, Richard B. Dewey, Rodger J. Elble, Richard S. Burns, Carlos Singer, Amy Parsons, John W. Taylor, Tracy Stewart, Maryan DeAngelis, Barbara C. Tilley, William J. Weiner, Brad A. Racette, Wendy R. Galpern, Michael J. Aminoff, Kapil D. Sethi, Jayaraman Rao, Robert A. Hauser, Debbie Fraser, Connie Kawai, David Coffey, Kelly E. Lyons, Kristine Wernette, Becky Dunlop, Holly Delgado, Marlene Lind, Rajesh Pahwa, Chris Weaver, Ray L. Watts, Patricia Deppen, Ryan J. Uitti, Marwan N. Sabbagh, Lynn Marlor, Joann Belden, Burton L. Scott, Theresa McClain, Roger L. Albin, John Y. Fang, Zoran Obradov, Yuko Y. Palesch, Maureen Cook, Pamela Andrews, Jeana Jaglin, Joanne Wojcieszek, Mary Louise Musante Weeks, Susan Peterson, James H. Bower, Maureen A. Leehey, Joanne Field, Lisa M. Shulman, Caroline M. Tanner, Jacob I. Sage, Jordan J. Elm, Joseph Jankovic, Patrick D. Mauldin, Aileen Shinaman, Peng Huang, G. Frederick Wooten, Alicia Brocht, Gordon H. Brown, Peggy Roberge, Dorothy Shearon, Buff Dill, Margaret F. Keller, Charlene Young, Christine Hunter, Janis M. Miyasaki, Susan Torgrimson, Cornelia Kamp, Brigid Hayward, Christopher G. Goetz, Emily Kosa, Marilyn Flewellen, David Simon, Rebecca McMurray, Sue Reichwein, Jacci Bainbridge, Robert W. Hamill, Stephanie Terashita, Kathleen M. Shannon, Frederick Wooten, Danna Jennings, Shana Krstevska, Bernard Ravina
Publikováno v:
Neurology. 68:20-28
Objective: To determine if future studies of coenzyme Q10 and GPI-1485 in Parkinson disease (PD) may be warranted. Methods: We conducted a randomized, double-blind, calibrated futility clinical trial of coenzyme Q10 and GPI-1485 in early untreated PD
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::36f17ff7b2eee66f71cf67f7561841fe
https://doi.org/10.1212/01.wnl.0000250355.28474.8e
https://doi.org/10.1212/01.wnl.0000250355.28474.8e
Autor:
H Christopher, Hyson, Karl, Kieburtz, Ira, Shoulson, Michael, McDermott, Bernard, Ravina, Elisabeth A, de Blieck, Merit E, Cudkowicz, Robert J, Ferrante, Peter, Como, Sam, Frank, Carol, Zimmerman, Kimberly, Ferrante, Kristyn, Newhall, Danna, Jennings, Tammie, Kelsey, Francis, Walker, Vicki, Hunt, Susan, Daigneault, Michele, Goldstein, Joseph, Weber, Arthur, Watts, M Flint, Beal, Susan E, Browne, Linda J, Metakis
Publikováno v:
Movement disorders : official journal of the Movement Disorder Society. 25(12)
Coenzyme Q10 (CoQ(10)), a potential neuroprotective compound, was previously investigated at a dosage of 600 mg/day in Huntington's disease (HD) patients and demonstrated a trend toward slowing disease progression. Higher CoQ(10) dosages may prove be
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::132468d80c70a2558f024c43eb71626b
https://pubmed.ncbi.nlm.nih.gov/20669312
https://pubmed.ncbi.nlm.nih.gov/20669312